Mario Motta, MD, joins COLA Inc. Board of Directors
The FDA has issued an alert on Biotin in blood or other samples taken from patients who are ingesting high levels of biotin in dietary supplements can cause clinically significant incorrect lab test results. The FDA has seen an increase in the number of reported adverse events, including one death, related to biotin interference with lab tests.
Click here to see the FDA’s full alert.
Related posts
